Diltiazem: The Latest Calcium-Channel Blocker
Karen Swisher Kesten, Nancy Swisher Reuter, Jill DeBoy Swisher
Abstract
Karen Swisher Kesten, Nancy Swisher Reuter, Jill DeBoy Swisher
Abstract
Diltiazem, the newest calcium- channel blocker released in the United States, has been beneficial for the treatment of the patient with coronary artery disease. The authors focus on the assessment of the patient receiving the drug, safe administration and undesired effects of the drug, and recommendations which ensure maximal effects of this new drug for the patient with coronary artery disease.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Diltiazem, the newest calcium- channel blocker released in the United States, has been beneficial for the treatment of the patient with coronary artery disease. The authors focus on the assessment of the patient receiving the drug, safe administration and undesired effects of the drug, and recommendations which ensure maximal effects of this new drug for the patient with coronary artery disease.
Key concepts: Diltiazem, Calcium channel blocker, Coronary artery disease, Medicine, Drug, Calcium channel, Cardiology, Internal medicine